PREDICTOM is inviting general practitioners to take part in our survey. With the aim of identifying current clinical guidelines and practice for screening, identifying and diagnosing Alzheimer's Disease and early dementia, we want to hear your views.
Photo: Svein Lunde, Helse Stavanger
Published 10 February 2025
Share this article
We are inviting general practitioners to complete this short survey. It should take around 10 minutes to complete. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.
Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation in primary care settings.
What if checking your brain health was as easy as a quick test on your phone or tablet? For millions worried about memory slips, that could be life-changing. Thanks to BrainCheck, this isn’t a dream—it’s happening now.
Could forgetting a PIN be more than a simple slip? Scientists behind the Banking App believe that subtle changes in how we handle financial tasks may signal early cognitive decline, including Alzheimer’s disease. By simulating ATM interactions, the app captures detailed performance metrics—such as speed, accuracy, and error patterns—that researchers use to study functional changes before traditional symptoms appear.
Eye-tracking technology is emerging as a promising tool for early detection of cognitive decline. By analyzing involuntary eye movements, researchers can identify subtle cognitive and attentional changes that may accompany the earliest stages of mild cognitive impairment and Alzheimer’s disease — sometimes before these changes are evident on traditional paper-based tests. This article explores the science, clinical applications, and innovations driving this breakthrough.
